RU2000121556A - New tricyclic derivatives (options), pharmaceutical composition (options), method for suppressing an immune response or treating and / or preventing allergic diseases (options) - Google Patents
New tricyclic derivatives (options), pharmaceutical composition (options), method for suppressing an immune response or treating and / or preventing allergic diseases (options)Info
- Publication number
- RU2000121556A RU2000121556A RU2000121556/04A RU2000121556A RU2000121556A RU 2000121556 A RU2000121556 A RU 2000121556A RU 2000121556/04 A RU2000121556/04 A RU 2000121556/04A RU 2000121556 A RU2000121556 A RU 2000121556A RU 2000121556 A RU2000121556 A RU 2000121556A
- Authority
- RU
- Russia
- Prior art keywords
- optionally substituted
- ring
- ness
- alkyl
- compound
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 6
- 201000005794 allergic hypersensitivity disease Diseases 0.000 title claims 5
- 230000028993 immune response Effects 0.000 title claims 4
- 230000001629 suppression Effects 0.000 title claims 4
- 150000001875 compounds Chemical class 0.000 claims 81
- 125000000217 alkyl group Chemical group 0.000 claims 60
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 53
- 150000003839 salts Chemical class 0.000 claims 48
- 239000011780 sodium chloride Substances 0.000 claims 48
- 229910052736 halogen Inorganic materials 0.000 claims 32
- 150000002367 halogens Chemical class 0.000 claims 32
- 125000003545 alkoxy group Chemical group 0.000 claims 30
- 125000003342 alkenyl group Chemical group 0.000 claims 22
- 125000000623 heterocyclic group Chemical group 0.000 claims 20
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 19
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 16
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 8
- 150000003230 pyrimidines Chemical group 0.000 claims 8
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 125000005842 heteroatoms Chemical group 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 5
- PBMFSQRYOILNGV-UHFFFAOYSA-N Pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 4
- 125000004423 acyloxy group Chemical group 0.000 claims 4
- 125000003302 alkenyloxy group Chemical group 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 125000003373 pyrazinyl group Chemical group 0.000 claims 4
- 150000003222 pyridines Chemical class 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims 3
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims 3
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims 3
- -1 atom hydrogen Chemical class 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 230000001861 immunosuppresant Effects 0.000 claims 3
- 239000003018 immunosuppressive agent Substances 0.000 claims 3
- 150000003217 pyrazoles Chemical group 0.000 claims 3
- IOJUPLGTWVMSFF-UHFFFAOYSA-N Benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims 2
- 125000006323 alkenyl amino group Chemical group 0.000 claims 2
- 125000005108 alkenylthio group Chemical group 0.000 claims 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N furane Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000002971 oxazolyl group Chemical group 0.000 claims 2
- 125000004193 piperazinyl group Chemical group 0.000 claims 2
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 2
- 125000001425 triazolyl group Chemical group 0.000 claims 2
- 239000000043 antiallergic agent Substances 0.000 claims 1
- 239000012267 brine Substances 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- RLZZZVKAURTHCP-UHFFFAOYSA-N phenanthrene-3,4-diol Chemical group C1=CC=C2C3=C(O)C(O)=CC=C3C=CC2=C1 RLZZZVKAURTHCP-UHFFFAOYSA-N 0.000 claims 1
- 125000005338 substituted cycloalkoxy group Chemical group 0.000 claims 1
- 0 **C(CC1)CCC1c(c(*)c1*)c(*)c(*)c1-c1c(*)c(*)c(**)c(*)c1* Chemical compound **C(CC1)CCC1c(c(*)c1*)c(*)c(*)c1-c1c(*)c(*)c(**)c(*)c1* 0.000 description 3
Claims (49)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10/15554 | 1998-01-28 | ||
JP1555498 | 1998-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2000121556A true RU2000121556A (en) | 2003-06-27 |
RU2216533C2 RU2216533C2 (en) | 2003-11-20 |
Family
ID=11891998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2000121556/04A RU2216533C2 (en) | 1998-01-28 | 1999-01-26 | Novel tricyclic derivatives (variants), pharmaceutical composition (variants), method for inhibition of immune response or treatment and/or prophylaxis of allergic diseases (variants) |
Country Status (17)
Country | Link |
---|---|
US (1) | US6562817B1 (en) |
EP (1) | EP1052238A4 (en) |
JP (1) | JP3929700B2 (en) |
KR (2) | KR100404358B1 (en) |
CN (1) | CN1231440C (en) |
AU (1) | AU742641B2 (en) |
BR (1) | BR9908539A (en) |
CA (1) | CA2318368C (en) |
HU (1) | HUP0103304A3 (en) |
ID (1) | ID24959A (en) |
IL (1) | IL137511A0 (en) |
NO (1) | NO20003706L (en) |
NZ (1) | NZ506101A (en) |
PL (1) | PL341984A1 (en) |
RU (1) | RU2216533C2 (en) |
TR (1) | TR200002225T2 (en) |
WO (1) | WO1999038829A1 (en) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1941797A (en) | 1997-03-17 | 1998-10-12 | Mitsubishi Denki Kabushiki Kaisha | Image encoder, image decoder, image encoding method, image decoding method and image encoding/decoding system |
WO2001005768A1 (en) * | 1999-07-19 | 2001-01-25 | Shionogi & Co., Ltd. | Tricyclic compounds bearing acyloxymethoxycarbonyl pendants |
TR200200099T2 (en) | 1999-07-23 | 2002-06-21 | Shionogi &Co., Ltd. | Th2 differentiation inhibitors |
PL356487A1 (en) | 1999-11-10 | 2004-06-28 | Takeda Chemical Industries, Ltd. | 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
MXPA02007868A (en) | 2000-02-16 | 2003-02-10 | Neurogen Corp | Substituted arylpyrazines. |
AR029489A1 (en) | 2000-03-10 | 2003-07-02 | Euro Celtique Sa | PIRIDINES, PYRIMIDINES, PIRAZINAS, TRIAZINES REPLACED BY ARILO, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
CN1431896A (en) * | 2000-04-04 | 2003-07-23 | 盐野义制药株式会社 | Oily compsns. contg. highly fat-soluble drugs |
AU2001244610A1 (en) * | 2000-04-05 | 2001-10-23 | Shionogi And Co., Ltd. | Oil-in-water microemulsions containing tricyclic compounds or preconcentrates thereof |
WO2002002539A1 (en) * | 2000-06-29 | 2002-01-10 | Abbott Laboratories | Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
CA2432642A1 (en) | 2000-12-21 | 2002-08-08 | Subhash P. Khanapure | Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
JPWO2002057237A1 (en) * | 2001-01-22 | 2004-05-20 | 塩野義製薬株式会社 | Heterotricyclic compound having a substituted amino group |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6887875B2 (en) * | 2001-06-12 | 2005-05-03 | Neurogen Corporation | 2,5-diarypyrimidine compounds |
US6706703B2 (en) * | 2001-06-29 | 2004-03-16 | Kowa Co., Ltd. | Bis(5-aryl-2-pyridyl) derivatives |
US6890940B2 (en) * | 2001-06-29 | 2005-05-10 | Kowa Co., Ltd. | Bis(2-aryl-5-pyridyl) derivatives |
AR037233A1 (en) | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | PIRIDINAS ARIL REPLACED, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT |
AR036873A1 (en) | 2001-09-07 | 2004-10-13 | Euro Celtique Sa | PIRIDINAS ARIL REPLACED A, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT |
WO2003030905A1 (en) * | 2001-10-01 | 2003-04-17 | Shionogi & Co., Ltd. | Dihydroorotate dehydrogenase inhibitor |
TW200302728A (en) | 2002-02-01 | 2003-08-16 | Novartis Ag | Substituted amines as IgE inhibitors |
CA2496197A1 (en) | 2002-08-20 | 2004-03-04 | Neurogen Corporation | 5-substituted-2-arylpyrazines as modulators of crf receptors |
AU2003271117A1 (en) * | 2002-10-09 | 2004-05-04 | Ssp Co., Ltd. | Novel pyrazole compounds having antifungal activity |
PL378402A1 (en) * | 2003-02-06 | 2006-04-03 | Basf Aktiengesellschaft | Pyrimidines, methods for the production thereof, and use thereof |
GB2400101A (en) * | 2003-03-28 | 2004-10-06 | Biofocus Discovery Ltd | Compounds capable of binding to the active site of protein kinases |
US7244739B2 (en) * | 2003-05-14 | 2007-07-17 | Torreypines Therapeutics, Inc. | Compounds and uses thereof in modulating amyloid beta |
WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
JP2008505957A (en) * | 2004-07-14 | 2008-02-28 | ビーエーエスエフ アクチェンゲゼルシャフト | 2-substituted pyrimidines, their preparation and their use for controlling harmful fungi |
EP1731587B1 (en) * | 2005-06-03 | 2013-01-23 | Merck Patent GmbH | Process for the preparation of tolanes |
WO2007034279A2 (en) * | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | C3a antagonists and pharmaceutical compositions thereof |
US20070254926A1 (en) * | 2006-01-31 | 2007-11-01 | Jun Jiang | Pyridylphenyl compounds for inflammation and immune-related uses |
NZ571203A (en) * | 2006-03-31 | 2011-12-22 | Novartis Ag | Monocyclic heteroaryl-phenyl-cyclohexyl compounds for treating diseases mediated by DGAT-1 activity |
RU2009126418A (en) * | 2006-12-11 | 2011-01-20 | Новартис АГ (CH) | METHOD FOR PREVENTION OR TREATMENT OF MYOCARDIAL ISCHEMIA |
PT2190825E (en) | 2007-08-22 | 2014-07-16 | Irm Llc | 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
WO2010029576A2 (en) | 2008-09-02 | 2010-03-18 | Elder Pharmaceuticals Ltd. | Anti inflammatory compounds |
WO2010042652A2 (en) | 2008-10-08 | 2010-04-15 | Amira Pharmaceuticals, Inc. | Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors |
PT2424843E (en) | 2009-04-30 | 2014-06-02 | Novartis Ag | Imidazole derivatives and their use as modulators of cyclin dependent kinases |
US9199975B2 (en) | 2011-09-30 | 2015-12-01 | Asana Biosciences, Llc | Biaryl imidazole derivatives for regulating CYP17 |
US8809372B2 (en) | 2011-09-30 | 2014-08-19 | Asana Biosciences, Llc | Pyridine derivatives |
EP3250034B1 (en) * | 2015-01-30 | 2020-03-11 | Basf Se | Herbicidal phenylpyrimidines |
HUE057970T2 (en) | 2018-03-08 | 2022-06-28 | Incyte Corp | Aminopyrazine diol compounds as pi3k-y inhibitors |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1262292A (en) | 1968-04-09 | 1972-02-02 | Wyeth John & Brother Ltd | Novel thiazoline derivatives, the preparation thereof and compositions containing the same |
JPS5191259A (en) | 1975-02-04 | 1976-08-10 | 55 arukokishi 44 okisazoorusakusan oyobi puropionsanjudotaino seizoho | |
FR2301250A1 (en) | 1975-02-21 | 1976-09-17 | Bellon Labor Sa Roger | 3-Omega dialkyl amino alkoxy 1,4-diaryl 1H-pyrazoles - analgesics and antiinflammatories prepd. from 3-hydroxy pyrazoles and alkyl halides |
JPS58121225A (en) | 1982-01-04 | 1983-07-19 | メルク・パテント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Bbc brown boveri & cie |
EP0084194B1 (en) * | 1982-01-14 | 1986-04-30 | MERCK PATENT GmbH | Liquid crystal mixtures |
ZA865090B (en) * | 1985-07-22 | 1988-02-24 | Riker Laboratories Inc | Substituted di-t-butylphenols |
JPS6322044A (en) * | 1986-07-14 | 1988-01-29 | Nippon Iyakuhin Kogyo Kk | 1,2-dihydronaphthalene derivative and production thereof |
JPS63119425A (en) * | 1986-11-07 | 1988-05-24 | Yoshitomi Pharmaceut Ind Ltd | Immune function improver |
WO1988007992A1 (en) | 1987-04-07 | 1988-10-20 | Pavljuchenko Assya I | Liquid-crystal derivatives of 2,5-disubstituted pyridine as components of liquid-crystal material, and a liquid-crystal material |
US4791200A (en) | 1987-06-22 | 1988-12-13 | Ortho Pharmaceutical Corporation | 2-substituted-4-aryl-substituted thiazoles |
JPS6443856A (en) | 1987-08-11 | 1989-02-16 | Canon Kk | Data recording system |
US4895953A (en) * | 1987-09-30 | 1990-01-23 | American Home Products Corporation | 2-Aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
DE3742716A1 (en) * | 1987-12-14 | 1989-06-22 | Schering Ag | IMIDAZOLE DERIVATIVES II |
JPH02500274A (en) * | 1987-12-30 | 1990-02-01 | パフルユチェンコ,アススヤ イオシフォフナ | Liquid crystal derivatives of 2,5-disubstituted pyridines as components of liquid crystal materials and liquid crystal materials |
ES2015648A6 (en) * | 1989-05-05 | 1990-09-01 | Consejo Superior Investigacion | Process for the synthesis of mono and bis (3-R3-4-R4-5-R5- pyrazol-1-yl)-1,4-dihydroxybenzenes |
JPH0348666A (en) | 1989-07-17 | 1991-03-01 | Rasa Kogyo Kk | Production of aromatic diamine compound |
JPH0717628B2 (en) * | 1989-07-27 | 1995-03-01 | ダイソー株式会社 | Liquid crystalline compound and its use |
JPH03263483A (en) * | 1990-03-13 | 1991-11-22 | Toshiba Corp | Lactic acid derivative and liquid crystal element using liquid crystal material containing same derivative |
JP2829451B2 (en) | 1990-11-30 | 1998-11-25 | 大塚製薬株式会社 | Active oxygen suppressant |
JP2786336B2 (en) * | 1991-03-04 | 1998-08-13 | 富士写真フイルム株式会社 | Immunoassay element and immunoassay method |
JP2621060B2 (en) * | 1991-03-12 | 1997-06-18 | 三田工業株式会社 | Paper cassette unit for image forming apparatus |
DE4112451A1 (en) | 1991-04-12 | 1992-10-15 | Schering Ag | ISOXAZOLYLIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS |
JPH057732A (en) | 1991-07-01 | 1993-01-19 | Takuma Sogo Kenkyusho:Kk | Denitration of exhaust gas by light reaction |
JPH09506101A (en) * | 1993-12-07 | 1997-06-17 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Heterocyclic biphenylylamides useful as 5HT1D antagonists |
JPH083163A (en) | 1994-06-22 | 1996-01-09 | Kyowa Hakko Kogyo Co Ltd | Condensed pyridine derivative |
JP3759772B2 (en) * | 1994-11-29 | 2006-03-29 | 杏林製薬株式会社 | Acrylamide derivative and method for producing the same |
CN1051552C (en) | 1994-11-29 | 2000-04-19 | 杏林制药株式会社 | Acrylamide derivatives and process for producing the same |
DE69629413T2 (en) * | 1995-04-24 | 2004-04-01 | Semiconductor Energy Laboratory Co., Ltd., Atsugi | Liquid crystal compound and liquid crystal composition containing it |
JPH09124571A (en) | 1995-11-01 | 1997-05-13 | Japan Tobacco Inc | Amide and its use |
ATE236130T1 (en) | 1996-01-26 | 2003-04-15 | Searle & Co | HETEROCYCLIC SUBSTITUTED IMIDAZOLES FOR THE TREATMENT OF INFLAMMATION |
DE19620041A1 (en) | 1996-05-17 | 1998-01-29 | Merck Patent Gmbh | Adhesion receptor antagonists |
WO1998056785A1 (en) | 1997-06-12 | 1998-12-17 | Sumitomo Pharmaceuticals Co., Ltd. | Pyrazole derivatives |
GB9725782D0 (en) * | 1997-12-05 | 1998-02-04 | Pfizer Ltd | Therapeutic agents |
JP3667067B2 (en) | 1997-12-18 | 2005-07-06 | キヤノン株式会社 | Print processing apparatus, control method therefor, and storage medium |
-
1999
- 1999-01-26 WO PCT/JP1999/000297 patent/WO1999038829A1/en not_active Application Discontinuation
- 1999-01-26 AU AU19837/99A patent/AU742641B2/en not_active Ceased
- 1999-01-26 BR BR9908539-9A patent/BR9908539A/en not_active Application Discontinuation
- 1999-01-26 US US09/600,790 patent/US6562817B1/en not_active Expired - Fee Related
- 1999-01-26 IL IL13751199A patent/IL137511A0/en unknown
- 1999-01-26 NZ NZ506101A patent/NZ506101A/en unknown
- 1999-01-26 KR KR10-2003-7007178A patent/KR100404358B1/en not_active IP Right Cessation
- 1999-01-26 EP EP99900676A patent/EP1052238A4/en not_active Withdrawn
- 1999-01-26 TR TR2000/02225T patent/TR200002225T2/en unknown
- 1999-01-26 RU RU2000121556/04A patent/RU2216533C2/en not_active IP Right Cessation
- 1999-01-26 CN CNB998043451A patent/CN1231440C/en not_active Expired - Fee Related
- 1999-01-26 JP JP2000530068A patent/JP3929700B2/en not_active Expired - Fee Related
- 1999-01-26 KR KR1020007007884A patent/KR20010034220A/en active Search and Examination
- 1999-01-26 CA CA002318368A patent/CA2318368C/en not_active Expired - Fee Related
- 1999-01-26 ID IDW20001457A patent/ID24959A/en unknown
- 1999-01-26 HU HU0103304A patent/HUP0103304A3/en unknown
- 1999-01-26 PL PL99341984A patent/PL341984A1/en unknown
-
2000
- 2000-07-19 NO NO20003706A patent/NO20003706L/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2000121556A (en) | New tricyclic derivatives (options), pharmaceutical composition (options), method for suppressing an immune response or treating and / or preventing allergic diseases (options) | |
RU2216533C2 (en) | Novel tricyclic derivatives (variants), pharmaceutical composition (variants), method for inhibition of immune response or treatment and/or prophylaxis of allergic diseases (variants) | |
RU2336275C2 (en) | Pyrimidine derivatives, characterised by antiproliferative activity, and pharmaceutical composition | |
AU2009319048B2 (en) | Pharmaceutical combination comprising a Hsp 90 inhibitor and a mTOR inhibitor | |
AU2006212761B2 (en) | Combination therapy | |
RU2005109911A (en) | Phenyl-Aza-Benzimidazole Compounds for IGE Modulation and Inhibition of Cell Growth | |
US20130303543A1 (en) | Protection of renal tissues from ischemia through inhibition of the proliferative kinases cdk4 and cdk6 | |
RU2002103201A (en) | Th2 differentiation inhibitors | |
CA2407593A1 (en) | Fused heteroaryl derivatives | |
DE69925141D1 (en) | CHINAZOLINE DERIVATIVES | |
KR900004333A (en) | Angiogenesis inhibitors | |
CA2126465C (en) | Inhibitor for restenosis after percutaneous coronary arterioplasty | |
WO2000042026B1 (en) | Non-peptide glp-1 agonists | |
CA2444130A1 (en) | Adenine derivatives | |
KR930702292A (en) | Quinazolin derivatives for enhancing tumor therapeutic activity | |
RU2005127873A (en) | Pyrazole derivatives | |
BR0015193A (en) | Compound, pharmaceutical composition, use of a compound, and, method for treating a condition associated with reduced nicotine transmission, for treatment or prophylaxis of psychotic disorders or disorders of intellectual impairment and for treatment or prophylaxis of human diseases or conditions | |
RU2006139258A (en) | KINAZ BENZOTRIAZINE INHIBITORS | |
RU2007103831A (en) | Pyrazole derivatives | |
RU2005106350A (en) | COMPOSITION AND DERIVATIVES OF SUBSTITUTED AZAINDOLOXOACETAPIPERASIN POSSESSING ANTIVIRAL ACTIVITY | |
RU2006107371A (en) | FLUORENE DERIVATIVES | |
JPH08509486A (en) | Use of thiazolidinediones for the treatment of atherosclerosis and dietary disorders | |
KR920006322A (en) | Benzene, pyridine and pyrimidine derivatives | |
JPH0558894A (en) | Antitumor agent | |
JP2009504673A (en) | A combination comprising a protein kinase inhibitor which is a pyrimidylaminobenzamide compound and an HSP90 inhibitor such as 17-AAG |